Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot trial

AIM: Double-blind placebo-controlled intervention using glutamic acid decarboxylase (GAD)-alum, vitamin D and Ibuprofen in recent onset Type I diabetes (T1D). METHODS: 64 patients (T1D since <4 months, age 10–17.99, fasting sC-peptide ≥0.12 nmol/l, GADA-positive) were randomized into Day(D) 1–90...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludvigsson, Johnny, Routray, Indusmita, Elluru, Sriramulu, Leanderson, Per, Larsson, Helena E, Rathsman, Björn, Hanås, Ragnar, Carlsson, Annelie, Ek, Torben, Samuelsson, Ulf, Torbjörnsdotter, Torun, Åman, Jan, Örtqvist, Eva, Badwal, Karun, Beam, Craig, Casas, Rosaura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421935/
https://www.ncbi.nlm.nih.gov/pubmed/32802401
http://dx.doi.org/10.2144/fsoa-2020-0078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421935/
https://www.ncbi.nlm.nih.gov/pubmed/32802401
http://dx.doi.org/10.2144/fsoa-2020-0078

Ejemplares similares